Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$0.34 - $0.65 $2,034 - $3,889
-5,984 Reduced 59.8%
4,022 $1,000
Q2 2023

Aug 08, 2023

SELL
$0.37 - $1.88 $58,191 - $295,677
-157,275 Reduced 94.02%
10,006 $3,000
Q1 2023

May 11, 2023

BUY
$1.75 - $2.7 $8,359 - $12,897
4,777 Added 2.94%
167,281 $304,000
Q4 2022

Feb 14, 2023

BUY
$1.72 - $4.1 $1,991 - $4,747
1,158 Added 0.72%
162,504 $336,000
Q3 2022

Nov 10, 2022

BUY
$2.92 - $4.88 $27,699 - $46,291
9,486 Added 6.25%
161,346 $486,000
Q2 2022

Aug 11, 2022

BUY
$3.2 - $7.0 $438,540 - $959,308
137,044 Added 924.97%
151,860 $486,000
Q1 2022

May 12, 2022

BUY
$6.45 - $14.67 $30,927 - $70,342
4,795 Added 47.85%
14,816 $96,000
Q4 2021

Feb 10, 2022

BUY
$8.92 - $15.66 $89,387 - $156,928
10,021 New
10,021 $134,000

Others Institutions Holding HLTH

About Cue Health Inc.


  • Ticker HLTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 148,152,992
  • Description
  • Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of ...
More about HLTH
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.